Real-time enrollment status for this myotonic dystrophy type 1 (dm1) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:43 PM UTC
| NCT Number | NCT07486934 |
| Recruiting Status | Recruiting |
| Condition | Myotonic Dystrophy Type 1 (DM1) |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Dyne Therapeutics |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07486934 is currently recruiting participants. This phase3 study for myotonic dystrophy type 1 (dm1) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Dyne Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07486934 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07486934 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.